씨앤에스헬스

비상장계속사업자

CNSHEALTH

최우혁, 성병윤

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

씨앤에스헬스

Business Reg. No. 2258801697 · CEO 최우혁, 성병윤

I.Investment Overview

Target씨앤에스헬스 (2258801697)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명씨앤에스헬스
영문명CNSHEALTH
대표자최우혁, 성병윤
사업자등록번호2258801697
법인등록번호1345110427086
설립일2020.01.03

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW0.3202110202210.1202310.2202410.22025
영업이익100M KRW-0.720216.920227.720237.9202482025
순이익100M KRW1.320212.320221.520232.620242.92025
Item20252024202320222021
자산총계147.7억원148.2억원149.9억원152억원130.8억원
부채총계135.4억원138.8억원143억원146.6억원127.8억원
자본총계12.3억원9.4억원6.8억원5.3억원3.1억원
매출액10.2억원10.2억원10.1억원10억원3,026만원
영업이익8억원7.9억원7.7억원6.9억원-6,996만원
순이익2.9억원2.6억원1.5억원2.3억원1.3억원

VI.Financial Ratios

FY2025 basis

78.57%

영업이익률

28.07%

순이익률

1.93%

ROA

23.29%

ROE

1,104.54%

부채비율

8.3%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

씨앤에스헬스 투심보고서 | Alpha Lenz